Malaria vaccines.
Although the possibility of a live attenuated malaria vaccine has been considered, current malaria vaccine development activities are dominated by attempts to develop a subunit vaccine. Hence, it is entirely appropriate that a session of the Molecular Approaches to Malaria conference, Lorne, Australia, 2-5 February 2000, was devoted to vaccine development. The oral presentations in this session and the relevant poster presentations are outlined here by Robin Anders and Allan Saul.
Anders
R F
RF
The Department of Biochemistry, La Trobe University, Bundoora, 3083, Victoria, Australia. R.Anders@latrobe.edu.au
Saul
A
A
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D006801:Humans; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology*
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins